Form 4 for INVA Innoviva, Inc.
Accepted 2022-04-27 00:00:00 ET · period of report 2022-04-25 · accession 0001567619-22-009041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-27 | 2022-04-25 | INVA | Odysseas Kostas D | Dir | A - Grant | $0.00 | +12.6K | 92.2K | +16% | $0 |
| D | 2022-04-27 | 2022-04-25 | INVA | Odysseas Kostas D | Dir | A - Grant | $10,000.00 | +10.0K | 0 | New | +$100.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-25 | A | A | 12,647 | $0.00 | 92,207 | D | — | — | (F1) The Reporting Person was granted restricted stock units ("RSUs") and options upon the conclusion of the Issuer's 2022 annual meeting of stockholders. 100% of the RSUs and options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date. |
| 2 | Derivative | Non-statutory Stock Option | 2022-04-25 | A | A | 10,000 | $10,000.00 | 0 | D | $17.79 · 2023-04-25 to 2032-04-24 | 0 Common Stock |